Key facts
- This page summarizes Vincent Brancaccio's Form 3 filing for Singular Genomics Systems, Inc..
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 26 May 2021, 20:32.
Vincent Brancaccio - 26 May 2021 Form 3 Insider Report for Singular Genomics Systems, Inc.
- Reporting relationship
- Vice President, HR
- Issuer ticker
- N/A
- Reported as of
- 26 May 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Vincent Brancaccio
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Vincent Brancaccio filed Form 3 for Singular Genomics Systems, Inc. on 26 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OMIC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 32,500
- Date
- 26 May 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OMIC
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 26 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $8.95
- Footnotes
- F1
OMIC
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 26 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $0.6900
- Footnotes
- F2
OMIC
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 26 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 87,500
- Exercise price
- $0.6300
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Option granted under the Singular Genomics Systems, Inc. 2016 Stock Plan. The option shares vest and become exercisable in 48 equal monthly installments beginning on April 1, 2021.
Footnote F2
Option granted under the Singular Genomics Systems, Inc. 2016 Stock Plan. The option shares vest and become exercisable in 48 equal monthly installments beginning on October 23, 2020.
Footnote F3
Option granted under the Singular Genomics Systems, Inc. 2016 Stock Plan. 25% of the the option shares vest and become exercisable on September 23, 2020, the remainder of the option shares vest in 36 equal monthly installments thereafter, beginning on October 23, 2020.
SEC remarks
Exhibit 24 - Power of Attorney